GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Operating Margin %

ClouDr Group (HKSE:09955) Operating Margin % : -6.86% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. ClouDr Group's Operating Income for the six months ended in Dec. 2023 was HK$-142 Mil. ClouDr Group's Revenue for the six months ended in Dec. 2023 was HK$2,065 Mil. Therefore, ClouDr Group's Operating Margin % for the quarter that ended in Dec. 2023 was -6.86%.

The historical rank and industry rank for ClouDr Group's Operating Margin % or its related term are showing as below:

HKSE:09955' s Operating Margin % Range Over the Past 10 Years
Min: -100.02   Med: -35.35   Max: -8.61
Current: -8.61


HKSE:09955's Operating Margin % is ranked worse than
86.73% of 98 companies
in the Medical Distribution industry
Industry Median: 3.035 vs HKSE:09955: -8.61

ClouDr Group's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

ClouDr Group's Operating Income for the six months ended in Dec. 2023 was HK$-142 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-348 Mil.

Warning Sign:

ClouDr Group Ltd has never been profitable in the past 3 years. It lost money every year.


ClouDr Group Operating Margin % Historical Data

The historical data trend for ClouDr Group's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Operating Margin % Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
-35.35 -100.02 -40.31 -18.94 -8.61

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial -37.88 -20.11 -17.95 -10.45 -6.86

Competitive Comparison of ClouDr Group's Operating Margin %

For the Medical Distribution subindustry, ClouDr Group's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClouDr Group's Operating Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's Operating Margin % distribution charts can be found below:

* The bar in red indicates where ClouDr Group's Operating Margin % falls into.



ClouDr Group Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

ClouDr Group's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-347.547 / 4036.63
=-8.61 %

ClouDr Group's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-141.562 / 2065.024
=-6.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ClouDr Group  (HKSE:09955) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


ClouDr Group Operating Margin % Related Terms

Thank you for viewing the detailed overview of ClouDr Group's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ClouDr Group (HKSE:09955) Business Description

Traded in Other Exchanges
Address
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

ClouDr Group (HKSE:09955) Headlines

No Headlines